Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/23/26 21:01 | 4/22/26 | AXSM | Health | Drug | Pharmaceutical Preparations | Maizel Ari | NY | O | Chief Co | 2 | M.d | 1,899 | 126.58 | 0 | 15 | 0 | D | |||||||||||||||
4/23/26 21:01 | 4/22/26 | AXSM | Health | Drug | Pharmaceutical Preparations | Maizel Ari | NY | O | Chief Co | 2 | S.d | -1,899 | 126.58 | 0 | -15 | -100 | 0 | D | ||||||||||||||
2/27/26 19:00 | 2/26/26 | AXSM | Health | Drug | Pharmaceutical Preparations | Coleman Mark | NY | D | 4 | S.d | -4,162 | 85.07 | 0 | -49 | 476 | D | ||||||||||||||||
2/27/26 19:00 | 2/26/26 | AXSM | Health | Drug | Pharmaceutical Preparations | Jacobson Mark L. | NY | O | COO | 2 | M.d | 5,828 | 82.37 | 0 | 71 | 0 | D | |||||||||||||||
2/27/26 19:00 | 2/26/26 | AXSM | Health | Drug | Pharmaceutical Preparations | Jacobson Mark L. | NY | O | COO | 2 | S.d | -5,828 | 82.37 | 0 | -71 | -100 | 0 | D | ||||||||||||||
2/2/26 18:30 | 2/2/26 | AXSM | Health | Drug | Pharmaceutical Preparations | Tabuteau Herriot | NY | DOT | CEO | 2 | M.d | 6,275 | 96.81 | 0 | 65 | 1 | 7,352 | D | ||||||||||||||
2/2/26 18:30 | 2/2/26 | AXSM | Health | Drug | Pharmaceutical Preparations | Tabuteau Herriot | NY | DOT | CEO | 2 | S.d | -6,275 | 96.81 | 0 | -65 | 7,352 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |